| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35bce0b8363dc3e87c11597734a15083 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-52 |
| filingDate |
2014-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7336ae501b6357f640547d8990bc1f48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19fe59448be8f9abb4a3859c65edfa68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dbbacc9851e35aaa9d89e46db743e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be6ef819eb75e15a1170150bd9dd83b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d374479fe2bb35b3d998e0d9cf29d143 |
| publicationDate |
2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015036898-A2 |
| titleOfInvention |
Novel salts of crizotinib and their preparation |
| abstract |
The present invention relates to novel pharmaceutically acceptable substituted aryl acrylic acid addition salts of Crizotinib (I) or its hydrate or solvate thereof. The present invention further relates to processes for preparation of the said substituted aryl acrylic acid addition salts of Crizotinib (I). The present application also provides pharmaceutically acceptable substituted aryl acrylic acid addition salts of Crizotinib (I) or its hydrate or solvate useful as active pharmaceutical ingredient in pharmaceutical composition comprising thereof, possessing anti-cancer activity. |
| priorityDate |
2013-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |